Bernard Le Foll

16.7k total citations · 4 hit papers
328 papers, 11.6k citations indexed

About

Bernard Le Foll is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Bernard Le Foll has authored 328 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Cellular and Molecular Neuroscience, 115 papers in Pharmacology and 99 papers in Molecular Biology. Recurrent topics in Bernard Le Foll's work include Neurotransmitter Receptor Influence on Behavior (123 papers), Cannabis and Cannabinoid Research (105 papers) and Substance Abuse Treatment and Outcomes (71 papers). Bernard Le Foll is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (123 papers), Cannabis and Cannabinoid Research (105 papers) and Substance Abuse Treatment and Outcomes (71 papers). Bernard Le Foll collaborates with scholars based in Canada, United States and France. Bernard Le Foll's co-authors include Steven R. Goldberg, Pierre Sokoloff, Yann Le Strat, Jürgen Rehm, Jorge Díaz, Tony P. George, Shaul Lev‐Ran, Caroline Dubertret, Abhiram Pushparaj and Benoît Forget and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Bernard Le Foll

308 papers receiving 11.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies

2013 427 citations Bernard Le Foll, Jürgen Rehm et al. profile →
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations

2017 301 citations Benedikt Fischer, Cayley Russell et al. American Journal of Public Health profile →
Cannabis use and cannabis use disorder

2021 257 citations Bernard Le Foll, Wayne Hall et al. profile →
Tobacco and nicotine use

2022 154 citations Bernard Le Foll, Wayne Hall et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard Le Foll Canada	58	5.3k	4.5k	3.4k	1.7k	1.5k	328	11.6k
Jean Lud Cadet United States	71	9.4k 1.8×	2.7k 0.6×	5.4k 1.6×	1.2k 0.7×	2.2k 1.5×	359	17.5k
Kent E. Hutchison United States	54	3.5k 0.7×	1.7k 0.4×	1.6k 0.5×	2.0k 1.2×	2.7k 1.8×	225	9.5k
Marian W. Fischman United States	55	5.8k 1.1×	2.8k 0.6×	1.8k 0.5×	1.2k 0.7×	1.6k 1.0×	159	9.6k
Tony P. George Canada	53	2.0k 0.4×	2.3k 0.5×	2.9k 0.8×	1.4k 0.8×	1.1k 0.7×	257	10.5k
David A. Gorelick United States	52	2.8k 0.5×	4.3k 1.0×	1.1k 0.3×	1.5k 0.9×	927 0.6×	213	9.3k
Mary Jeanne Kreek United States	68	10.3k 1.9×	2.4k 0.5×	5.9k 1.7×	3.0k 1.8×	1.9k 1.2×	443	20.3k
Kenneth Blum United States	45	4.3k 0.8×	1.7k 0.4×	1.7k 0.5×	679 0.4×	1.6k 1.0×	420	9.6k
Mehmet Sofuoglu United States	49	3.0k 0.6×	1.2k 0.3×	2.0k 0.6×	1.2k 0.7×	846 0.6×	204	7.6k
Sandra D. Comer United States	52	2.9k 0.5×	2.7k 0.6×	1.0k 0.3×	1.9k 1.1×	869 0.6×	195	7.9k
Anne Lingford‐Hughes United Kingdom	45	2.9k 0.5×	2.0k 0.4×	1.1k 0.3×	1.2k 0.7×	1.6k 1.0×	184	7.4k

Countries citing papers authored by Bernard Le Foll

Since Specialization

Citations

This map shows the geographic impact of Bernard Le Foll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Le Foll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Le Foll more than expected).

Fields of papers citing papers by Bernard Le Foll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Le Foll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Le Foll. The network helps show where Bernard Le Foll may publish in the future.

Co-authorship network of co-authors of Bernard Le Foll

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Le Foll. A scholar is included among the top collaborators of Bernard Le Foll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Le Foll. Bernard Le Foll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rehm, Jürgen, Farihah Ali, Cayley Russell, et al.. (2025). Decriminalization of drug possession in British Columbia and hospitalizations for opioid poisoning. Public Health. 248. 105915–105915.

Imtiaz, Sameer, Huan Jiang, Cayley Russell, et al.. (2025). The Short‐Term Impacts of Decriminalisation of Personal Possession of Select Illegal Drugs on Drug Poisonings in British Columbia, Canada (2015–2023). Drug and Alcohol Review. 44(7). 1856–1865.

Zhao, Shankun, Bruna Brands, Christine M. Wickens, et al.. (2025). Association of driving with blood delta-9-tetrahydrocannabinol: a systematic review. The International Journal of Neuropsychopharmacology. 28(4). 2 indexed citations

Ciano, Patricia Di, Tarek K. Rajji, Patrick Byrne, et al.. (2024). Cannabis and Driving in Older Adults. JAMA Network Open. 7(1). e2352233–e2352233. 10 indexed citations

Fairbairn, Nadia, et al.. (2024). Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada. American Journal on Addictions. 33(6). 664–674. 3 indexed citations

Whitehurst, David G. T., Emanuel Krebs, Benjamin Enns, et al.. (2023). Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada. Quality of Life Research. 32(8). 2209–2221. 2 indexed citations

Chenoweth, Meghan J., Didier Jutras‐Aswad, Keith Ahamad, et al.. (2023). Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone. Clinical Pharmacology & Therapeutics. 115(3). 506–514.

Kim, Soyeon, et al.. (2023). The COVID‐19 impact and characterization on substance use‐related emergency department visits for adolescents and young adults in Canada: Practical implications. Journal of Evaluation in Clinical Practice. 29(3). 447–458. 7 indexed citations

Hauck, Tanya S., Karim S. Ladha, Bernard Le Foll, Duminda N. Wijeysundera, & Paul Kurdyak. (2023). Postoperative buprenorphine continuation in stabilized buprenorphine patients: A population cohort study. Addiction. 118(10). 1953–1964. 1 indexed citations

10.

Matheson, Justin, Robert E. Mann, Gina Stoduto, et al.. (2022). Effects of combining alcohol and cannabis on driving, breath alcohol level, blood THC, cognition, and subjective effects: A narrative review.. Experimental and Clinical Psychopharmacology. 30(6). 1036–1049. 9 indexed citations

11.

Ibrahim, Christine, Bernard Le Foll, & Ahmed N. Hassan. (2021). The Effect of Nicotine Dependence on the Risk of Developing Post-traumatic Stress Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Nicotine & Tobacco Research. 24(5). 719–727. 3 indexed citations

12.

Hassan, Ahmed N. & Bernard Le Foll. (2021). Survival Probabilities and Predictors of Major Depressive Episode Incidence Among Individuals With Various Types of Substance Use Disorders. The Journal of Clinical Psychiatry. 82(5). 9 indexed citations

13.

Minian, Nadia, Aliya Noormohamed, Laurie Zawertailo, et al.. (2021). Integrating a brief alcohol intervention with tobacco addiction treatment in primary care: qualitative study of health care practitioner perceptions. Addiction Science & Clinical Practice. 16(1). 17–17. 11 indexed citations

14.

Fischer, Benedikt, Cayley Russell, Pamela Sabioni, et al.. (2017). Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. American Journal of Public Health. 107(8). e1–e12. 301 indexed citations breakdown →

15.

Minian, Nadia, Dolly Baliunas, Laurie Zawertailo, et al.. (2017). Combining alcohol interventions with tobacco addictions treatment in primary care—the COMBAT study: a pragmatic cluster randomized trial. Implementation Science. 12(1). 65–65. 8 indexed citations

16.

Forget, Benoît, et al.. (2016). Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats. Psychopharmacology. 233(10). 1823–1828. 23 indexed citations

17.

Ciano, Patricia Di, et al.. (2015). The Impact of Selective Dopamine D2, D3 and D4 Ligands on the Rat Gambling Task. PLoS ONE. 10(9). e0136267–e0136267. 27 indexed citations

18.

Agic, Branka, Gina Stoduto, Anca Ialomiteanu, et al.. (2013). Characteristics of people who report both driving after drinking and driving after cannabis use. 3 indexed citations

19.

Zai, Clement C., Mirko Manchia, Vincenzo De Luca, et al.. (2010). Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case–control and family based study designs. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(8). 1412–1418. 17 indexed citations

20.

Foll, Bernard Le, Henri‐Jean Aubin, & G Lagrue. (2002). Les thérapies comportementales et cognitives dans l'aide à l'arrêt du tabac : Revue de la littérature et mise au point. 153(3). 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact